 <h1>Fanatrex Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>gabapentin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about gabapentin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Fanatrex.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to gabapentin: oral capsule, oral solution, oral suspension, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, gabapentin (the active ingredient contained in Fanatrex) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking gabapentin:</p><p>
<i>More common</i>
</p><ul>
<li>Clumsiness or unsteadiness</li>
<li>continuous, uncontrolled, back-and-forth, or rolling eye movements</li>
</ul><p>
<i>More common in children</i>
</p><ul>
<li>Aggressive behavior or other behavior problems</li>
<li>anxiety</li>
<li>concentration problems and change in school performance</li>
<li>crying</li>
<li>depression</li>
<li>false sense of well-being</li>
<li>hyperactivity or increase in body movements</li>
<li>rapidly changing moods</li>
<li>reacting too quickly, too emotional, or overreacting</li>
<li>restlessness</li>
<li>suspiciousness or distrust</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>depression, irritability, or other mood or mental changes</li>
<li>fever</li>
<li>loss of memory</li>
<li>pain or swelling in the arms or legs</li>
<li>painful or difficult urination</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swollen glands</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>clay-colored stools</li>
<li>coma</li>
<li>confusion</li>
<li>convulsions</li>
<li>dark urine</li>
<li>decreased urine output</li>
<li>diarrhea</li>
<li>difficult or troubled breathing</li>
<li>dizziness</li>
<li>fast or irregular heartbeat</li>
<li>headache</li>
<li>increased thirst</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>itching or skin rash</li>
<li>joint pain</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>loss of appetite</li>
<li>muscle ache or pain</li>
<li>nausea</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>unpleasant breath odor</li>
<li>vomiting of blood</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of gabapentin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>cold or flu-like symptoms</li>
<li>delusions</li>
<li>dementia</li>
<li>hoarseness</li>
<li>lack or loss of strength</li>
<li>lower back or side pain</li>
<li>swelling of the hands, feet, or lower legs</li>
<li>trembling or shaking</li>
</ul><p>
<i>Less common or rare</i>
</p><ul>
<li>Accidental injury</li>
<li>appetite increased</li>
<li>back pain</li>
<li>bloated or full feeling</li>
<li>body aches or pain</li>
<li>burning, dry, or itching eyes</li>
<li>change in vision</li>
<li>change in walking and balance</li>
<li>clumsiness or unsteadiness</li>
<li>congestion</li>
<li>constipation</li>
<li>cough producing mucus</li>
<li>decrease in sexual desire or ability</li>
<li>dryness of the mouth or throat</li>
<li>earache</li>
<li>excess air or gas in the stomach or intestines</li>
<li>excessive tearing</li>
<li>eye discharge</li>
<li>feeling faint, dizzy, or lightheadedness</li>
<li>feeling of warmth or heat</li>
<li>flushed, dry skin</li>
<li>flushing or redness of the skin, especially on the face and neck</li>
<li>frequent urination</li>
<li>fruit-like breath odor</li>
<li>impaired vision</li>
<li>incoordination</li>
<li>increased hunger</li>
<li>increased sensitivity to pain</li>
<li>increased sensitivity to touch</li>
<li>increased thirst</li>
<li>indigestion</li>
<li>noise in the ears</li>
<li>pain, redness, rash, swelling, or bleeding where the skin is rubbed off</li>
<li>passing gas</li>
<li>redness or swelling in the ear</li>
<li>redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>runny nose</li>
<li>sneezing</li>
<li>sweating</li>
<li>tender, swollen glands in the neck</li>
<li>tightness in the chest</li>
<li>tingling in the hands and feet</li>
<li>trouble sleeping</li>
<li>trouble swallowing</li>
<li>trouble thinking</li>
<li>twitching</li>
<li>unexplained weight loss</li>
<li>voice changes</li>
<li>vomiting</li>
<li>weakness or loss of strength</li>
<li>weight gain</li>
</ul><p>
<!-- end oral capsule, oral solution, oral suspension, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to gabapentin: compounding powder, oral capsule, oral solution, oral tablet, oral tablet extended release</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Peripheral edema, vasodilation, hypertension</p>
<p><b>Rare</b> (less than 0.1%): Atrial fibrillation, heart failure, myocardial infarction, cerebrovascular accident, ventricular extrasystoles, bradycardia, premature atrial contraction, pericardial rub, heart block, pericardial effusion, pericarditis </p>
<p><b>Postmarketing reports</b>: Cardiac arrest, chest pain, palpitation, tachycardia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Abrasion, facial edema, purpura, rash, pruritus, acne</p>
<p><b>Uncommon</b> (0.1% to 1%): Alopecia, eczema, dry skin, increased sweating, urticaria, hirsutism, seborrhea, cyst, herpes simplex</p>
<p><b>Rare</b> (less than 0.1%): Stevens-Johnson syndrome, angioedema, erythema multiforme, drug rash (with eosinophilia and systemic symptoms), herpes zoster, skin discolor, skin papules, photosensitive reaction, psoriasis, desquamation, maceration, skin nodules, subcutaneous nodule, melanosis, skin necrosis, local swelling </p>
<p><b>Frequency not reported</b>: DRESS/multiorgan hypersensitivity<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (less than 0.1%): Hyperthyroid, hypothyroid, goiter, hypoestrogenism, ovarian failure, epididymitis, cushingoid appearance<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, dry mouth or throat, constipation, nausea, vomiting, dyspepsia, dental abnormalities, gingivitis, abdominal pain, flatulence </p>
<p><b>Uncommon</b> (0.1% to 1%): Glossitis, gum hemorrhage, thirst, stomatitis, increased salivation, gastroenteritis, hemorrhoids, bloody stools, fecal incontinence </p>
<p><b>Rare</b> (less than 0.1%): Pancreatitis, dysphagia, eructation, pancreatitis, peptic ulcer, colitis, blisters in mouth, tooth discoloration, perlèche, salivary gland enlarged, lip hemorrhage, esophagitis, hiatal hernia, hematemesis, proctitis, irritable bowel syndrome, rectal hemorrhage, esophageal spasm</p>
<p><b>Frequency not reported</b>: Dehydration<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions associated with the use of this drug were dizziness, somnolence, and peripheral edema.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Incontinence, impotence</p>
<p><b>Uncommon</b> (0.1% to 1%): Hematuria, dysuria, urinary frequency, cystitis, urinary retention, vaginal hemorrhage, amenorrhea, dysmenorrhea, menorrhagia</p>
<p><b>Frequency not reported</b>: Breast hypertrophy, gynecomastia, sexual dysfunction (including changes in libido, ejaculation disorders, and anorgasmia)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Leucopenia, purpura</p>
<p><b>Uncommon</b> (0.1% to 1%): Anemia, lymphadenopathy</p>
<p><b>Rare</b> (less than 0.1%): Thrombocytopenia, thrombophlebitis, leukocytosis, lymphocytosis, increased bleeding time </p>
<p><b>Frequency not reported</b>: Blood creatine phosphokinase increased, coagulation defect<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Hepatitis, jaundice, elevated liver function tests SGOT (AST), SGPT (ALT), and bilirubin, hepatomegaly, hepatotoxicity<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity syndrome, a systemic reaction with a variable presentation that can include fever, rash, hepatitis, lymphadenopathy, eosinophilia, and sometimes other signs and symptoms<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight gain, hyperglycemia</p>
<p><b>Postmarketing reports</b>: Hyponatremia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, arthralgia, myalgia, twitching</p>
<p><b>Uncommon</b> (0.1% to 1%): Tendonitis, arthritis, joint stiffness, joint swelling </p>
<p><b>Frequency not reported</b>: Rhabdomyolysis, myoclonus</p>
<p><b>Postmarketing reports</b>: Elevated creatine kinase, rhabdomyolysis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence (21%), dizziness (17%), ataxia (13%)</p>
<p><b>Common</b> (1% to 10%): Abnormal gait, incoordination, neuralgia, tremor, dysarthria, hyperkinesia, seizures, dysarthria, paresthesia, hypesthesia, coordination abnormal, increased/decreased/absent reflexes, vertigo </p>
<p><b>Uncommon</b> (less than 1%): Hypokinesia</p>
<p><b>Rare</b> (less than 0.1%): Movement disorders (e.g., choreoathetosis, dyskinesia, dystonia), loss of consciousness </p>
<p><b>Frequency not reported</b>: Withdrawal precipitated seizure/status epilepticus</p>
<p><b>Postmarketing reports</b>: Movement disorder<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Amblyopia, conjunctivitis, diplopia, nystagmus</p>
<p><b>Uncommon</b> (0.1% to 1%): Cataract, dry eyes, eye pain, visual field defect, photophobia, bilateral or unilateral ptosis, eye hemorrhage, hordeolum, eye twitching</p>
<p><b>Rare</b> (less than 0.1%): Eye itching, abnormal accommodation, eye focusing problem, watery eyes, retinopathy, glaucoma, iritis, corneal disorders, lacrimal dysfunction, degenerative eye changes, blindness, retinal degeneration, miosis, chorioretinitis, strabismus<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Uncommon</b> (0.1% to 1%): Breast cancer</p>
<p><b>Rare</b> (less than 0.1%): Non-Hodgkin's lymphoma<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (11%), fever (11%)</p>
<p><b>Common</b> (1% to 10%): Asthenia, accidental injury, otitis media, tremor, pain</p>
<p><b>Rare</b> (0.01% to 0.1%): Tinnitus</p>
<p><b>Very rare</b> (less than 0.01%): Sudden unexplained death in patients with epilepsy </p>
<p><b>Frequency not reported</b>: Sleepwalking, withdrawal symptoms, hearing loss, earache, tinnitus, inner ear infection, otitis, taste loss, unusual taste, ear fullness, perforated ear drum, sensitivity to noise, eustachian tube dysfunction, otitis externa, odd smell, labyrinthitis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Abnormal thinking, amnesia, depression, hostility, confusion, emotional lability, anxiety, nervousness, insomnia</p>
<p><b>Uncommon</b> (0.1% to 1%): Mental impairment</p>
<p><b>Rare</b> (less than 0.1%): Hallucinations </p>
<p><b>Frequency not reported</b>: Suicidal behavior and ideation, hypomania<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (less than 0.1%): Acute renal failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, dyspnea, cough, bronchitis, respiratory infection, rhinitis</p>
<p><b>Rare</b> (less than 0.1%): Pulmonary thrombosis, pulmonary embolism</p>
<p><b>Frequency not reported</b>: Pseudo-croup, hoarseness<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Neurontin (gabapentin)." Parke-Davis, Morris Plains, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Sahin S,  Comert A,  Akin O,  Ayalp S,  Karsidag S "Cutaneous drug eruptions by current antiepileptics: case reports and alternative  treatment options." Clin Neuropharmacol 31 (2008): 93-6</p><p id="ref_5">5. Gidal BE, Maly MM, Nemire RE, Haley K "Weight gain and gabapentin therapy." Ann Pharmacother 29 (1995): 1048</p><p id="ref_6">6. Lasso-de-la-Vega MC,  Zapater P,  Such J,  Perez-Mateo M,  Horga JF "Gabapentin-associated hepatotoxicity." Am J Gastroenterol 96 (2001): 3460-2</p><p id="ref_7">7. Ragucci MV, Cohen JM "Gabapentin-induced hypersensitivity syndrome." Clin Neuropharmacol 24 (2001): 103-5</p><p id="ref_8">8. Zhang C,  Glenn DG,  Bell WL,  O'donovan CA "Gabapentin-induced Myoclonus in End-stage Renal Disease." Epilepsia 46 (2005): 156-158</p><p id="ref_9">9. The US, Gabapentin Study Group No. 5 "Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study." Neurology 43 (1993): 2292-8</p><p id="ref_10">10. Pittenger C,  Desan PH "Gabapentin abuse, and delirium tremens upon gabapentin withdrawal." J Clin Psychiatry 68 (2007): 483-4</p><p id="ref_11">11. Crawford P, Ghadiali E, Lane R, Blumhardt L, Chadwick D "Gabapentin as an antiepileptic drug in man." J Neurol Neurosurg Psychiatry 50 (1987): 682-6</p><p id="ref_12">12. Reeves AL, So EL, Sharbrough FW, Krahn LE "Movement disorders associated with the use of gabapentin." Epilepsia 37 (1996): 988-90</p><p id="ref_13">13. Tallian KB, Nahata MC, Lo W, Tsao CY "Gabapentin associated with aggressive behavior in pediatric patients with seizures." Epilepsia 37 (1996): 501-2</p><p id="ref_14">14. Short C, Cooke L "Hypomania induced by gabapentin." Br J Psychiatry 166 (1995): 679-80</p><p id="ref_15">15. Silvia RJ,  Spitznas AL "Gabapentin-Related Changes in Renal Function: Two Case Reports." J Clin Psychopharmacol 27 (2007): 118-119</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Lyrica vs Gabapentin: What's the difference?</li>
<li>Does it cause weight gain?</li>
<li>How long does withdrawal last?</li>
<li>Does it help you sleep?</li>
<li>Is this a narcotic/controlled substance?</li>
<li>Gabapentin, impotence and other problems?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Fanatrex (gabapentin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: gamma-aminobutyric acid analogs</li>
<li>FDA Alerts (4)</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Neurontin, Gralise, Gabarone</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Epilepsy</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to gabapentin: compounding powder, oral capsule, oral solution, oral tablet, oral tablet extended release</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Peripheral edema, vasodilation, hypertension</p><p><b>Rare</b> (less than 0.1%): Atrial fibrillation, heart failure, myocardial infarction, cerebrovascular accident, ventricular extrasystoles, bradycardia, premature atrial contraction, pericardial rub, heart block, pericardial effusion, pericarditis </p><p><b>Postmarketing reports</b>: Cardiac arrest, chest pain, palpitation, tachycardia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Abrasion, facial edema, purpura, rash, pruritus, acne</p><p><b>Uncommon</b> (0.1% to 1%): Alopecia, eczema, dry skin, increased sweating, urticaria, hirsutism, seborrhea, cyst, herpes simplex</p><p><b>Rare</b> (less than 0.1%): Stevens-Johnson syndrome, angioedema, erythema multiforme, drug rash (with eosinophilia and systemic symptoms), herpes zoster, skin discolor, skin papules, photosensitive reaction, psoriasis, desquamation, maceration, skin nodules, subcutaneous nodule, melanosis, skin necrosis, local swelling </p><p><b>Frequency not reported</b>: DRESS/multiorgan hypersensitivity<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (less than 0.1%): Hyperthyroid, hypothyroid, goiter, hypoestrogenism, ovarian failure, epididymitis, cushingoid appearance<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, dry mouth or throat, constipation, nausea, vomiting, dyspepsia, dental abnormalities, gingivitis, abdominal pain, flatulence </p><p><b>Uncommon</b> (0.1% to 1%): Glossitis, gum hemorrhage, thirst, stomatitis, increased salivation, gastroenteritis, hemorrhoids, bloody stools, fecal incontinence </p><p><b>Rare</b> (less than 0.1%): Pancreatitis, dysphagia, eructation, pancreatitis, peptic ulcer, colitis, blisters in mouth, tooth discoloration, perlèche, salivary gland enlarged, lip hemorrhage, esophagitis, hiatal hernia, hematemesis, proctitis, irritable bowel syndrome, rectal hemorrhage, esophageal spasm</p><p><b>Frequency not reported</b>: Dehydration<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions associated with the use of this drug were dizziness, somnolence, and peripheral edema.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Incontinence, impotence</p><p><b>Uncommon</b> (0.1% to 1%): Hematuria, dysuria, urinary frequency, cystitis, urinary retention, vaginal hemorrhage, amenorrhea, dysmenorrhea, menorrhagia</p><p><b>Frequency not reported</b>: Breast hypertrophy, gynecomastia, sexual dysfunction (including changes in libido, ejaculation disorders, and anorgasmia)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Leucopenia, purpura</p><p><b>Uncommon</b> (0.1% to 1%): Anemia, lymphadenopathy</p><p><b>Rare</b> (less than 0.1%): Thrombocytopenia, thrombophlebitis, leukocytosis, lymphocytosis, increased bleeding time </p><p><b>Frequency not reported</b>: Blood creatine phosphokinase increased, coagulation defect<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Hepatitis, jaundice, elevated liver function tests SGOT (AST), SGPT (ALT), and bilirubin, hepatomegaly, hepatotoxicity<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity syndrome, a systemic reaction with a variable presentation that can include fever, rash, hepatitis, lymphadenopathy, eosinophilia, and sometimes other signs and symptoms<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight gain, hyperglycemia</p><p><b>Postmarketing reports</b>: Hyponatremia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, arthralgia, myalgia, twitching</p><p><b>Uncommon</b> (0.1% to 1%): Tendonitis, arthritis, joint stiffness, joint swelling </p><p><b>Frequency not reported</b>: Rhabdomyolysis, myoclonus</p><p><b>Postmarketing reports</b>: Elevated creatine kinase, rhabdomyolysis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence (21%), dizziness (17%), ataxia (13%)</p><p><b>Common</b> (1% to 10%): Abnormal gait, incoordination, neuralgia, tremor, dysarthria, hyperkinesia, seizures, dysarthria, paresthesia, hypesthesia, coordination abnormal, increased/decreased/absent reflexes, vertigo </p><p><b>Uncommon</b> (less than 1%): Hypokinesia</p><p><b>Rare</b> (less than 0.1%): Movement disorders (e.g., choreoathetosis, dyskinesia, dystonia), loss of consciousness </p><p><b>Frequency not reported</b>: Withdrawal precipitated seizure/status epilepticus</p><p><b>Postmarketing reports</b>: Movement disorder<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Amblyopia, conjunctivitis, diplopia, nystagmus</p><p><b>Uncommon</b> (0.1% to 1%): Cataract, dry eyes, eye pain, visual field defect, photophobia, bilateral or unilateral ptosis, eye hemorrhage, hordeolum, eye twitching</p><p><b>Rare</b> (less than 0.1%): Eye itching, abnormal accommodation, eye focusing problem, watery eyes, retinopathy, glaucoma, iritis, corneal disorders, lacrimal dysfunction, degenerative eye changes, blindness, retinal degeneration, miosis, chorioretinitis, strabismus<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Uncommon</b> (0.1% to 1%): Breast cancer</p><p><b>Rare</b> (less than 0.1%): Non-Hodgkin's lymphoma<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (11%), fever (11%)</p><p><b>Common</b> (1% to 10%): Asthenia, accidental injury, otitis media, tremor, pain</p><p><b>Rare</b> (0.01% to 0.1%): Tinnitus</p><p><b>Very rare</b> (less than 0.01%): Sudden unexplained death in patients with epilepsy </p><p><b>Frequency not reported</b>: Sleepwalking, withdrawal symptoms, hearing loss, earache, tinnitus, inner ear infection, otitis, taste loss, unusual taste, ear fullness, perforated ear drum, sensitivity to noise, eustachian tube dysfunction, otitis externa, odd smell, labyrinthitis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Abnormal thinking, amnesia, depression, hostility, confusion, emotional lability, anxiety, nervousness, insomnia</p><p><b>Uncommon</b> (0.1% to 1%): Mental impairment</p><p><b>Rare</b> (less than 0.1%): Hallucinations </p><p><b>Frequency not reported</b>: Suicidal behavior and ideation, hypomania<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (less than 0.1%): Acute renal failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, dyspnea, cough, bronchitis, respiratory infection, rhinitis</p><p><b>Rare</b> (less than 0.1%): Pulmonary thrombosis, pulmonary embolism</p><p><b>Frequency not reported</b>: Pseudo-croup, hoarseness<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Neurontin (gabapentin)." Parke-Davis, Morris Plains, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. Sahin S,  Comert A,  Akin O,  Ayalp S,  Karsidag S "Cutaneous drug eruptions by current antiepileptics: case reports and alternative  treatment options." Clin Neuropharmacol 31 (2008): 93-6</p><p id="ref_5">5. Gidal BE, Maly MM, Nemire RE, Haley K "Weight gain and gabapentin therapy." Ann Pharmacother 29 (1995): 1048</p><p id="ref_6">6. Lasso-de-la-Vega MC,  Zapater P,  Such J,  Perez-Mateo M,  Horga JF "Gabapentin-associated hepatotoxicity." Am J Gastroenterol 96 (2001): 3460-2</p><p id="ref_7">7. Ragucci MV, Cohen JM "Gabapentin-induced hypersensitivity syndrome." Clin Neuropharmacol 24 (2001): 103-5</p><p id="ref_8">8. Zhang C,  Glenn DG,  Bell WL,  O'donovan CA "Gabapentin-induced Myoclonus in End-stage Renal Disease." Epilepsia 46 (2005): 156-158</p><p id="ref_9">9. The US, Gabapentin Study Group No. 5 "Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study." Neurology 43 (1993): 2292-8</p><p id="ref_10">10. Pittenger C,  Desan PH "Gabapentin abuse, and delirium tremens upon gabapentin withdrawal." J Clin Psychiatry 68 (2007): 483-4</p><p id="ref_11">11. Crawford P, Ghadiali E, Lane R, Blumhardt L, Chadwick D "Gabapentin as an antiepileptic drug in man." J Neurol Neurosurg Psychiatry 50 (1987): 682-6</p><p id="ref_12">12. Reeves AL, So EL, Sharbrough FW, Krahn LE "Movement disorders associated with the use of gabapentin." Epilepsia 37 (1996): 988-90</p><p id="ref_13">13. Tallian KB, Nahata MC, Lo W, Tsao CY "Gabapentin associated with aggressive behavior in pediatric patients with seizures." Epilepsia 37 (1996): 501-2</p><p id="ref_14">14. Short C, Cooke L "Hypomania induced by gabapentin." Br J Psychiatry 166 (1995): 679-80</p><p id="ref_15">15. Silvia RJ,  Spitznas AL "Gabapentin-Related Changes in Renal Function: Two Case Reports." J Clin Psychopharmacol 27 (2007): 118-119</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Lyrica vs Gabapentin: What's the difference?</li>
<li>Does it cause weight gain?</li>
<li>How long does withdrawal last?</li>
<li>Does it help you sleep?</li>
<li>Is this a narcotic/controlled substance?</li>
<li>Gabapentin, impotence and other problems?</li>
</ul><h2>More about Fanatrex (gabapentin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: gamma-aminobutyric acid analogs</li>
<li>FDA Alerts (4)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Epilepsy</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>